We propose to investigate the viral determinants of pathogenesis by the human immunodeficiency virus (HIV). There is abundant molecular, virologic, and epidemiologic evidence that viral cofactors, particularly Epstein-Barr virus (EBV), hepatitis B virus (HBV), and cytomegalovirus (CMV), may be involved in the pathogenesis of AIDS related complex (ARC) and AIDS. We therefore plan to examine the relationship of these viruses to HIV infected cells to determine if a cofactor relationship may exist in vivo. We plan to perform in situ hybridization and immunohistochemical staining on tissues and cells from individuals who are HIV seropositive and well, have ARC, have AIDs, and controls.
We aim to determine if cells demonstrating expression of HIV also show expression of EBV, HBV, or CMV or border or such cells. Numerous samples of lymphoid tissue, bone marrow, brain, and peripheral blood lymphocytes will be examined using the combined technique of in situ hybridization to detect HIV RNA and immunohistochemical staining to detect HIV RNA and immunohistochemical staining to detect EBV, HBV, or CMV antigen; in addition tissues will be examined using combined in situ hybridization to detect CMV or HBV RNA and immunohistochemical staining to detect expression of HIV antigen. In tissues derived from people without opportunistic infections, expression of CMV, HBV, or EBV in the same cells or cells neighboring those expressing HIV will add in vivo evidence to the already existing in vitro evidence that these viruses may act as cofactors in the progression of HIV infection. In addition, we shall perform a series of experiments to assay whether CMV or EBV can potentiate the production of HIV in vitro. If in vitro potentiation is demonstrated, we shall test to see if this effect can be blocked by agents that inhibit CMV or EBV replication.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Morrison, S A; Pearson, S L; Steigbigel, R T (1998) Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120. AIDS Res Hum Retroviruses 14:491-8
Schubach, W H; Horvath, G; LeVea, C et al. (1997) Chromatin structure of the lymphocyte Fc epsilon receptor gene (CD23): identification of an upstream transcriptional enhancer. J Immunol 158:2228-35
Moorjani, H; Craddock, B P; Morrison, S A et al. (1996) Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages. J Acquir Immune Defic Syndr Hum Retrovirol 13:18-22
Cohen, A J; Steigbigel, R T (1996) Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 174:615-8
Handley, M A; Steigbigel, R T; Morrison, S A (1996) A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages. J Virol 70:4451-6
O'Riordan, T G; Smaldone, G C (1994) Regional deposition and regional ventilation during inhalation of pentamidine. Chest 105:396-401
O'Riordan, T G; Palmer, L B; Smaldone, G C (1994) Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 149:214-9
O'Riordan, T G; Baughman, R P; Dohn, M N et al. (1994) Lobar pentamidine levels and Pneumocystis carinii pneumonia following aerosolized pentamidine. Chest 105:53-6
Nuovo, G J; Becker, J; Burk, M W et al. (1994) In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr 7:916-23
Suzuki, K; Craddock, B P; Okamoto, N et al. (1993) Detection of human immunodeficiency virus (HIV) by colorimetric assay for reverse transcriptase activity on magnetic beads. Biotechnol Appl Biochem 18 ( Pt 1):37-44

Showing the most recent 10 out of 27 publications